文献速递胃肠动力与功能性疾病

通过培养和高通量测序定义小肠细菌过度生长

Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-06-12

研究纳入接受食管胃十二指肠镜(未行结肠镜)的受试者,完成症状严重程度问卷,十二指肠抽吸液行MacConkey和血琼脂培养,抽吸物DNA行16S核糖体RNA和鸟枪法测序。结果发现≥10^3 CFU/mL为最佳小肠细菌过度生长阈值,与胃肠道症状、微生物多样性降低和网络破坏相关,且少数大肠埃希菌和克雷伯菌菌株/种主导 microbiome。

要点

  • ≥10^3 CFU/mL为小肠细菌过度生长最佳阈值,与胃肠道症状相关。
  • ≥10^3 CFU/mL受试者微生物α多样性逐渐降低,埃希菌/志贺菌和克雷伯菌相对丰度增加。
  • 碳水化合物发酵、产氢和产硫化氢代谢通路在≥10^3 CFU/mL受试者中增强并与症状相关。

核心结论

  • ≥10^3 CFU/mL是小肠细菌过度生长的最佳阈值,与胃肠道症状、微生物多样性显著降低和网络破坏相关。

研究设计与样本

  • 接受食管胃十二指肠镜(未行结肠镜)的受试者被招募并完成症状严重程度问卷,十二指肠抽吸液行MacConkey和血琼脂培养,抽吸物DNA行16S核糖体RNA和鸟枪法测序。

主要发现

  • 共385例受试者MacConkey琼脂菌落<10^3 CFU/mL,98例≥10^3 CFU/mL,其中≥10^3至<10^5 CFU/mL者66例,≥10^5 CFU/mL者32例。
  • 在≥10^3至<10^5 CFU/mL和≥10^5 CFU/mL受试者中,十二指肠微生物α多样性逐渐降低,埃希菌/志贺菌和克雷伯菌相对丰度增加。
  • 微生物网络连接性在这些受试者中也逐渐降低,由埃希菌(P < .0001)和克雷伯菌(P = .0018)相对丰度增加驱动。
  • 碳水化合物发酵、产氢和产硫化氢的微生物代谢通路在≥10^3 CFU/mL受试者中增强并与症状相关。
  • 鸟枪法测序(N = 38)在≥10^3 CFU/mL受试者中鉴定出2种主要大肠埃希菌菌株和2种克雷伯菌物种,占所有十二指肠细菌的40.24%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND& AIMS: Despite accelerated research in small intestinal bacterial overgrowth (SIBO), questions remain regarding optimal diagnostic approaches and definitions. Here, we aim to define SIBO using small bowel culture and sequencing, identifying specific contributory microbes, in the context of gastrointestinal symptoms. METHODS: Subjects undergoing esophagogastroduodenoscopy (without colonoscopy) were recruited and completed symptom severity questionnaires. Duodenal aspirates were plated on MacConkey and blood agar. Aspirate DNA was analyzed by 16S ribosomal RNA and shotgun sequencing. Microbial network connectivity for different SIBO thresholds and predicted microbial metabolic functions were also assessed. RESULTS: A total of 385 subjects with <103 colony forming units (CFU)/mL on MacConkey agar and 98 subjects with ≥103 CFU/mL, including ≥103 to <105 CFU/mL (N = 66) and ≥105 CFU/mL (N = 32), were identified. Duodenal microbial α-diversity progressively decreased, and relative abundance of Escherichia/Shigella and Klebsiella increased, in subjects with ≥103 to <105 CFU/mL and ≥105 CFU/mL. Microbial network connectivity also progressively decreased in these subjects, driven by the increased relative abundance of Escherichia (P < .0001) and Klebsiella (P = .0018). Microbial metabolic pathways for carbohydrate fermentation, hydrogen production, and hydrogen sulfide production were enhanced in subjects with ≥103 CFU/mL and correlated with symptoms. Shotgun sequencing (N = 38) identified 2 main Escherichia coli strains and 2 Klebsiella species representing 40.24% of all duodenal bacteria in subjects with ≥103 CFU/mL. CONCLUSIONS: Our findings confirm ≥103 CFU/mL is the optimal SIBO threshold, associated with gastrointestinal symptoms, significantly decreased microbial diversity, and network disruption. Microbial hydrogen- and hydrogen sulfide-related pathways were enhanced in SIBO subjects, supporting past studies. Remarkably few specific E coli and Klebsiella strains/species appear to dominate the microbiome in SIBO, and correlate with abdominal pain, diarrhea, and bloating severities.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Leite G, Rezaie A, Mathur R, et al. Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing. Clin Gastroenterol Hepatol. 2023. PMID: 37315761. doi:10.1016/j.cgh.2023.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。